Research indicated that in patients with advanced AD, AChE levels can decline significantly while BChE levels may increase, suggesting a compensatory mechanism where BChE attempts to hydrolyze ACh in the absence of sufficient AChE activity [92]. This evidence concerns the gene ACHE and Alzheimer disease.